Dive into the archives.
- LATE BREAKING: New Phase III Data for Cladribine to be Presented at AAN
CLARITY (CLAdRIbine tablets Treating MS OrallY) Study Data to be Presented as Late-Breaking Oral Presentation By: PR Newswire Mar. 30, 2009 08:01 AM // GENEVA, Switzerland, March 30 /PRNewswire/ — Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the American Academy of Neurology (AAN) has accepted a late-breaking abstract regarding cladribine [...]
- Breast Feeding Works Miracles for Both Baby and Mother with MS
AAN 2009: Breast-Feeding May Reduce Multiple Sclerosis Relapses Allison Gandey February 23, 2009 — Women who have multiple sclerosis (MS) may reduce their risk for relapse after pregnancy if they breast-feed, a new study suggests. “Our findings call into question the benefit of choosing not to breast-feed or stopping breast-feeding early in order to start [...]
